Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1951 1
1960 1
1961 1
1962 1
1972 1
1974 2
1975 2
1976 5
1977 4
1979 3
1980 5
1981 6
1982 3
1983 8
1984 7
1985 4
1986 10
1987 5
1988 3
1989 6
1990 10
1991 9
1992 6
1993 16
1994 10
1995 7
1996 14
1997 8
1998 15
1999 7
2000 15
2001 16
2002 19
2003 14
2004 17
2005 15
2006 24
2007 22
2008 19
2009 22
2010 30
2011 27
2012 42
2013 64
2014 70
2015 63
2016 60
2017 77
2018 59
2019 84
2020 98
2021 81
2022 64
2023 57
2024 19

Text availability

Article attribute

Article type

Publication date

Search Results

1,103 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Digestive system neuroendocrine neoplasm"
Page 1
Neuroendocrine neoplasms of the esophagus and stomach.
Mastracci L, Rindi G, Grillo F, Solcia E, Campora M, Fassan M, Parente P, Vanoli A, La Rosa S. Mastracci L, et al. Pathologica. 2021 Feb;113(1):5-11. doi: 10.32074/1591-951X-229. Pathologica. 2021. PMID: 33686305 Free PMC article. Review.
Esophageal neuroendocrine neoplasms (E-NENs) are much rarer than other gastro-entero-pancreatic neuroendocrine neoplasms, the majority showing aggressive behavior with early dissemination and poor prognosis. Among E-NENs, exceptionally rare well differentiated ne …
Esophageal neuroendocrine neoplasms (E-NENs) are much rarer than other gastro-entero-pancreatic neuroendocrine neoplasms, the …
What is New in the 2019 World Health Organization (WHO) Classification of Tumors of the Digestive System: Review of Selected Updates on Neuroendocrine Neoplasms, Appendiceal Tumors, and Molecular Testing.
Assarzadegan N, Montgomery E. Assarzadegan N, et al. Arch Pathol Lab Med. 2021 Jun 1;145(6):664-677. doi: 10.5858/arpa.2019-0665-RA. Arch Pathol Lab Med. 2021. PMID: 32233993 Free PMC article. Review.
.-: The 5th edition of the World Health Organization classification of digestive system tumors discusses several advancements and developments in understanding the etiology, pathogenesis, and diagnosis of several digestive tract tumors. OBJECTIV …
.-: The 5th edition of the World Health Organization classification of digestive system tumors discusses several advanc …
(177)Lu-Dotatate plus long-acting octreotide versus high-dose long-acting octreotide in patients with midgut neuroendocrine tumours (NETTER-1): final overall survival and long-term safety results from an open-label, randomised, controlled, phase 3 trial.
Strosberg JR, Caplin ME, Kunz PL, Ruszniewski PB, Bodei L, Hendifar A, Mittra E, Wolin EM, Yao JC, Pavel ME, Grande E, Van Cutsem E, Seregni E, Duarte H, Gericke G, Bartalotta A, Mariani MF, Demange A, Mutevelic S, Krenning EP; NETTER-1 investigators. Strosberg JR, et al. Lancet Oncol. 2021 Dec;22(12):1752-1763. doi: 10.1016/S1470-2045(21)00572-6. Epub 2021 Nov 15. Lancet Oncol. 2021. PMID: 34793718 Clinical Trial.
Patients were 18 years and older with locally advanced or metastatic, well differentiated, somatostatin receptor-positive midgut neuroendocrine tumours (Karnofsky performance status score 60) and disease progression on fixed-dose long-acting octreotide. Patients wer …
Patients were 18 years and older with locally advanced or metastatic, well differentiated, somatostatin receptor-positive midgut neuroend …
Diagnosis of digestive system tumours.
Washington MK, Goldberg RM, Chang GJ, Limburg P, Lam AK, Salto-Tellez M, Arends MJ, Nagtegaal ID, Klimstra DS, Rugge M, Schirmacher P, Lazar AJ, Odze RD, Carneiro F, Fukayama M, Cree IA; WHO Classification of Tumours Editorial Board. Washington MK, et al. Int J Cancer. 2021 Mar 1;148(5):1040-1050. doi: 10.1002/ijc.33210. Epub 2020 Nov 19. Int J Cancer. 2021. PMID: 32674220 Free article. Review.
The first volume to be produced is on the classification of Digestive System tumours, replacing the successful 2010 version. It has been rewritten and updated accordingly. ...This makes the classification relevant to many disciplines involved in the care of patients …
The first volume to be produced is on the classification of Digestive System tumours, replacing the successful 2010 version. I …
Autoimmune gastritis: Pathologist's viewpoint.
Coati I, Fassan M, Farinati F, Graham DY, Genta RM, Rugge M. Coati I, et al. World J Gastroenterol. 2015 Nov 14;21(42):12179-89. doi: 10.3748/wjg.v21.i42.12179. World J Gastroenterol. 2015. PMID: 26576102 Free PMC article. Review.
In advanced cases, the oxyntic epithelia are replaced by atrophic (and metaplastic) mucosa, creating the phenotypic background in which both gastric neuroendocrine tumors and (intestinal-type) adenocarcinomas may develop. Despite improvements in our understanding of …
In advanced cases, the oxyntic epithelia are replaced by atrophic (and metaplastic) mucosa, creating the phenotypic background in which both …
Narrative Review of Immunotherapy in Gastroentero-Pancreatic Neuroendocrine Neoplasms.
Kaur J, Vijayvergia N. Kaur J, et al. Curr Oncol. 2023 Sep 21;30(9):8653-8664. doi: 10.3390/curroncol30090627. Curr Oncol. 2023. PMID: 37754542 Free PMC article. Review.
Gastroentero-pancreatic Neuroendocrine Neoplasms (GEP-NENs) are a diverse group of rare tumors that arise from neuroendocrine cells in the gastrointestinal tract and pancreas, and they can vary significantly in terms of clinical behavior and prognosis. ...Obj …
Gastroentero-pancreatic Neuroendocrine Neoplasms (GEP-NENs) are a diverse group of rare tumors that arise from neuroendocri …
Cyto-histology in NET: what is necessary today and what is the future?
Inzani F, Petrone G, Fadda G, Rindi G. Inzani F, et al. Rev Endocr Metab Disord. 2017 Dec;18(4):381-391. doi: 10.1007/s11154-017-9428-x. Rev Endocr Metab Disord. 2017. PMID: 28871510 Review.
Neuroendocrine cancer is most frequently observed in the lung and the digestive tract. In the lung is defined as carcinoid (typical and atypical) for well differentiated, low to intermediate grade, and small cell and large cell neuroendocrine carcinoma …
Neuroendocrine cancer is most frequently observed in the lung and the digestive tract. In the lung is defined as carcin …
Looking into digestive mixed neuroendocrine - nonneuroendocrine neoplasms: subtypes, prognosis, and predictive factors.
Uccella S, La Rosa S. Uccella S, et al. Histopathology. 2020 Nov;77(5):700-717. doi: 10.1111/his.14178. Epub 2020 Sep 12. Histopathology. 2020. PMID: 32538468 Review.
Mixed neuroendocrine - nonneuroendocrine neoplasms (MiNENs) of the digestive system represent a challenge for both pathologists and clinicians. ...This review will provide: a historical background that helps in understanding the evolution of the concept and n …
Mixed neuroendocrine - nonneuroendocrine neoplasms (MiNENs) of the digestive system represent a challenge for both path …
Role of Somatostatin Signalling in Neuroendocrine Tumours.
Rogoza O, Megnis K, Kudrjavceva M, Gerina-Berzina A, Rovite V. Rogoza O, et al. Int J Mol Sci. 2022 Jan 27;23(3):1447. doi: 10.3390/ijms23031447. Int J Mol Sci. 2022. PMID: 35163374 Free PMC article. Review.
Somatostatin (SST) is a small peptide that exerts inhibitory effects on a wide range of neuroendocrine cells. Due to the fact that somatostatin regulates cell growth and hormone secretion, somatostatin receptors (SSTRs) have become valuable targets for the treatment of dif …
Somatostatin (SST) is a small peptide that exerts inhibitory effects on a wide range of neuroendocrine cells. Due to the fact that so …
The clinical and prognostic factors for biliary neuroendocrine neoplasm: a study based on the SEER database.
Zheng BH, Zhang C, Wan WZ, Sun WT, Cheng X, Ni XJ, Ni XL, Suo T, Liu H, Shen S, Liu HB. Zheng BH, et al. BMC Surg. 2022 Jun 29;22(1):253. doi: 10.1186/s12893-022-01689-7. BMC Surg. 2022. PMID: 35768809 Free PMC article.
BACKGROUND: In this study, we aimed at elucidating the postoperative survival and prognostic factors in patients with biliary neuroendocrine neoplasm (NEN). METHODS: Cases of biliary system NEN and adenocarcinoma from 1975 to 2016 were extracted from the Surv …
BACKGROUND: In this study, we aimed at elucidating the postoperative survival and prognostic factors in patients with biliary neuroendocr …
1,103 results